|
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
RECRUITINGPhase 3Sponsored by Suven Life Sciences Limited
Actively Recruiting
PhasePhase 3
SponsorSuven Life Sciences Limited
Started2022-11-01
Est. completion2026-12
Eligibility
Age50 Years – 90 Years
Healthy vol.Accepted
Locations27 sites
View on ClinicalTrials.gov →
NCT05397639
Summary
This study will be conducted to evaluate the efficacy, safety, tolerability, and pharmacokinetics of masupirdine compared to placebo for the treatment of agitation in participants with dementia of the Alzheimer's type.
Eligibility
Age: 50 Years – 90 YearsHealthy volunteers accepted
Inclusion Criteria: * Has a diagnosis of dementia of the Alzheimer's type according to the National Institute on Aging-Alzheimer's Association (NIA-AA) criteria. * Has confirmed agitation using the IPA Consensus Provisional Definition of Agitation in Cognitive Disorders. * Has a score between 8 and 24 (both inclusive) on Mini-Mental State Examination (MMSE). Exclusion Criteria: * Participants with dementia predominantly of the non-Alzheimer's type (e.g., vascular dementia, parkinson's disease, lewy body disease, frontotemporal dementia) * Has symptoms of agitation that are not secondary to Alzheimer's disease (eg, pain, other psychiatric disorder, or delirium due to a metabolic disorder, systemic infection, or substance-induced). * Participant (or caregiver) is deemed otherwise ineligible for participation in this study in the investigator's judgement.
Conditions3
AgitationAlzheimer's DiseaseAlzheimer's Type Dementia
Interventions2
Locations27 sites
Find trials near these locations
Alzheimer's Disease trials in FresnoAlzheimer's Disease trials in Los AngelesAlzheimer's Disease trials in MiamiAlzheimer's Disease trials in OrlandoAlzheimer's Disease trials in ChicagoAlzheimer's Disease trials in Fort WorthAlzheimer's Disease trials in HoustonAll trials in CaliforniaAll trials in FloridaAll trials in IllinoisAll trials in New YorkAll trials in OhioAll trials in Texas
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 3
SponsorSuven Life Sciences Limited
Started2022-11-01
Est. completion2026-12
Eligibility
Age50 Years – 90 Years
Healthy vol.Accepted
Locations27 sites
View on ClinicalTrials.gov →
NCT05397639